Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04284839 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Study acronym: DANCE
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 16 words Site details revised at 2 of 19 sites · Publications: details revised at 1 of 1 entry Show 2 more changesShow less
    • Site details revised at 2 of 19 sites
    • Publications: details revised at 1 of 1 entry
  2. Study sites: 16 to 19v9
  3. Site contacts updated at 11 of 16 sites Study description expanded, about 1 wordv8 Show 1 more changeShow less
    • Study description expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  4. Site contacts updated at 2 of 16 sitesv7
  5. Study sites: 7 to 16v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 1 to 7v5
  2. Enrollment target: 6215 to 3500 Eligibility criteria expanded, about 19 words · Study title expanded, about 2 wordsv4 Show 2 more changesShow less
    • Eligibility criteria expanded, about 19 words
    • Study title expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  3. Primary and study completion dates: Mar 2024 to Jun 2027 Eligibility criteria expanded, about 10 words · Secondary endpoints revised (9) · Study description expanded, about 95 wordsv3 Show 3 more changesShow less
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints revised (9)
    • Study description expanded, about 95 words

    See this version in full on ClinicalTrials.gov ↗

  4. Lead sponsor: McMaster University to Population Health Research Institute Trial status: Not Yet Recruiting to Recruiting · Primary and study completion dates: Mar 2023 to Mar 2024 · Start date changed from estimate of Mar 2020 to Jul 18, 2021 · 6 morev2 Show 9 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Mar 2023 to Mar 2024
    • Start date changed from estimate of Mar 2020 to Jul 18, 2021
    • Enrollment target: 5900 to 6215
    • Eligibility criteria shortened, about 13 words
    • Secondary endpoints: 6 to 9
    • Study description expanded, about 101 words
    • Site details revised
    • Collaborators expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The DANCE Trial is a multi-centre, randomized controlled trial comparing the safety of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) in the early period (30 days) after cardiac surgery in patients with atrial fibrillation requiring oral anticoagulation.
Trial Details
NCT Number NCT04284839
Lead Sponsor Population Health Research Institute
Collaborators: Hamilton Health Sciences Corporation
Conditions Bleeding Post Cardiac Surgery, Indication for Anticoagulation
Enrollment 3,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov